|
2025
|
Invention
|
Engineered polypeptides and uses thereof.
Polypeptides, such as antibody molecules and fusion pr... |
|
|
Invention
|
Humanized complement 5a receptor 1 antibodies and methods of use thereof.
The present disclosure... |
|
2024
|
Invention
|
Interleukin-2 agents and uses thereof.
IL-2 agents that comprise IL-2 variants are disclosed as ... |
|
|
Invention
|
Antibody molecules to april and uses thereof.
Antibody molecules that specifically bind to APRIL... |
|
|
Invention
|
Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (april).
Antibody ... |
|
|
Invention
|
Methods of using interleukin-2 agents.
IL-2 agents that comprise IL-2 variants are disclosed as ... |
|
|
Invention
|
Antibody molecules to dengue virus and uses thereof.
Antibody molecules that specifically bind t... |
|
|
Invention
|
Apelin receptor agonists and uses thereof. The present invention provides, among other things, ap... |
|
|
Invention
|
Interleukin-2 agents and uses thereof. IL-2 agents that comprise IL-2 variants are disclosed as w... |
|
|
Invention
|
Antibody molecules to cd138 and uses thereof.
Antibody molecules that specifically bind to CD138... |
|
|
Invention
|
Antibody molecule-drug conjugates and uses thereof.
Antibody molecule-drug conjugates (ADCs) tha... |
|
|
Invention
|
Formulations of antibody molecules to dengue virus.
This disclosure relates to formulations of p... |
|
|
Invention
|
Humanized complement 5a receptor 1 antibodies and methods of use thereof. The present disclosure ... |
|
2023
|
Invention
|
Binding polypeptides and methods of making the same.
Polypeptides, such as antibody molecules an... |
|
|
Invention
|
Antibody molecules to c5ar1 and uses thereof. Antibody molecules that specifically bind to C5aR1 ... |
|
|
Invention
|
Treatment of complement mediated diseases and disorders with c3b antibodies.
The present inventi... |
|
|
Invention
|
Treatment of complement mediated diseases and disorders with c3b-antibodies. The present inventio... |
|
|
Invention
|
Immunosilencing fc variants.
The present disclosure provides, among other things Fc variants tha... |
|
|
Invention
|
Antibody molecules to april and uses thereof. Antibody molecules that specifically bind to APRIL ... |
|
|
Invention
|
Interleukin-2 muteins for the treatment of autoimmune diseases. IL-2 agents that comprise IL-2 va... |
|
|
Invention
|
Anti-idiotype antibody molecules and uses thereof.
Antibody molecules that specifically bind to ... |
|
|
Invention
|
Anti-idiotype antibody molecules and uses thereof. Antibody molecules that specifically bind to a... |
|
2022
|
Invention
|
Methods of using interleukin-2 agents.
Methods of using IL-2 fusion proteins to treat and/or pre... |
|
|
Invention
|
Methods of using interleukin-2 agents. Methods of using IL-2 fusion proteins to treat and/or prev... |
|
|
Invention
|
Engineered antibody molecules to cd138 and uses thereof.
Antibody molecules that specifically bi... |
|
|
Invention
|
Engineered antibody molecules to cd138 and uses thereof. Antibody molecules that specifically bin... |
|
|
Invention
|
Fc variants with abolished binding to fcgammar and c1q. The present disclosure provides, among ot... |
|
|
Invention
|
Interleukin-2 mutants and uses thereof. IL-2 agents that comprise IL-2 variants are disclosed as ... |
|
2021
|
Invention
|
Methods of using interleukin-2 agents. IL-2 agents that comprise IL-2 variants are disclosed as w... |
|
|
Invention
|
Method of using antibody molecules to detect a proliferation-inducing ligand (april). Antibody mo... |
|
|
Invention
|
Antibody molecules to dengue virus and uses thereof. Antibody molecules that specifically bind to... |
|
|
P/S
|
Pharmaceutical preparations and therapeutic agents in the nature of biologics for pharmaceutical ... |
|
|
P/S
|
Pharmaceutical preparations and therapeutic agents in the
nature of biologics for pharmaceutical... |
|
|
Invention
|
Antibody molecule-drug conjugates and uses thereof. Antibody molecule-drug conjugates (ADCs) that... |
|
2020
|
Invention
|
Compositions and methods for treating and preventing influenza.
This disclosure relates to bindi... |
|
|
Invention
|
Ha binding agents. This disclosure relates to novel peptide agents, e.g., antibodies and antigen-... |
|
2019
|
Invention
|
Methods for identifying epitopes and paratopes.
Disclosed are methods of identifying an epitope ... |
|
2016
|
P/S
|
Pharmaceutical preparations, therapeutic agents, human vaccines, assays, detection test kits cons... |
|
2013
|
P/S
|
research and development services and technical consultation relating to the development and scie... |
|
2010
|
P/S
|
Pharmaceutical preparations, therapeutic agents, vaccines,
assays, test kits and surveillance to... |
|
|
P/S
|
pharmaceutical preparations and therapeutic agents in the nature of biologics for pharmaceutical ... |
